International pharmaceutical outsourcing services provider PCI Pharma Services (PCI) will be at Pharmapack 2018 February 7-8 at the Paris expo Porte de Versailles, to showcase their serialization expertise and EU presence. PCI plans to highlighting their ongoing investment and expansion to triple serialization capacity in Europe, alongside North America.
PCI has serializing commercial drug product for more than six years, expanding global capacity in advance of meeting the implementation deadlines for the European Falsified Medicines Directive (EU FMD). Their program has entailed a series of technological and facility developments at its sites in Europe and North America to benefit its global supply network.
PCI has also been investing in its core business and key site expansion in cold chain infrastructure and capacity. PCI has expanded its EU footprint with its most recent acquisition in Ireland, and site expansions at its Tredegar and Bridgend facilities in the UK, helping to support pharmaceutical and biotech companies looking to address potential concerns regarding Brexit uncertainty.
